X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (218) 218
Publication (19) 19
Book Chapter (6) 6
Conference Proceeding (2) 2
Book / eBook (1) 1
Book Review (1) 1
Patent (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (116) 116
index medicus (91) 91
endocrinology & metabolism (86) 86
female (76) 76
male (76) 76
middle aged (73) 73
adult (68) 68
aged (61) 61
tumors (31) 31
somatostatin - analogs & derivatives (24) 24
young adult (23) 23
oncology (22) 22
abridged index medicus (21) 21
expression (17) 17
adolescent (16) 16
diagnosis (16) 16
management (16) 16
somatostatin (16) 16
aged, 80 and over (15) 15
disease (15) 15
octreotide - therapeutic use (15) 15
prognosis (15) 15
treatment outcome (15) 15
cancer (14) 14
neuroendocrine tumors (14) 14
somatostatin - therapeutic use (14) 14
therapy (14) 14
in-vitro (13) 13
retrospective studies (13) 13
surgery (13) 13
medicine & public health (12) 12
prospective studies (12) 12
research (12) 12
secretion (12) 12
mortality (11) 11
octreotide - analogs & derivatives (11) 11
patients (11) 11
receptors, somatostatin - metabolism (11) 11
tumor cells, cultured (11) 11
acromegaly - drug therapy (10) 10
animals (10) 10
corticosteroids (10) 10
cushing syndrome (10) 10
dopamine (10) 10
follow-up studies (10) 10
growth-hormone (10) 10
hormones (10) 10
neuroendocrine tumors - pathology (10) 10
octreotide (10) 10
pituitary (10) 10
quality-of-life (10) 10
somatostatin - pharmacology (10) 10
cortisol (9) 9
hydrocortisone (9) 9
internal medicine (9) 9
paraganglioma (9) 9
pituitary neoplasms - drug therapy (9) 9
rna, messenger - metabolism (9) 9
survival (9) 9
cell line, tumor (8) 8
child (8) 8
cushing's syndrome (8) 8
dopamine agonists - therapeutic use (8) 8
health aspects (8) 8
metastases (8) 8
octreotide - pharmacology (8) 8
receptor (8) 8
receptors, somatostatin - genetics (8) 8
adrenal cortex neoplasms - pathology (7) 7
adrenocortical carcinoma - pathology (7) 7
analysis (7) 7
carcinoma (7) 7
case-control studies (7) 7
diabetes (7) 7
dose-response relationship, drug (7) 7
enets consensus guidelines (7) 7
glucocorticoids (7) 7
hydrocortisone - metabolism (7) 7
metastasis (7) 7
octreotide - adverse effects (7) 7
pancreas (7) 7
pharmacology & pharmacy (7) 7
pituitary acth hypersecretion - drug therapy (7) 7
predictive value of tests (7) 7
prevalence (7) 7
time factors (7) 7
transsphenoidal surgery (7) 7
acth (6) 6
adenoma (6) 6
adrenal cortex neoplasms - genetics (6) 6
adrenal cortex neoplasms - metabolism (6) 6
adrenal glands (6) 6
adrenocortical carcinoma - genetics (6) 6
adrenocortical carcinoma - metabolism (6) 6
adrenocorticotropic hormone (6) 6
antineoplastic agents, hormonal - therapeutic use (6) 6
article (6) 6
cells (6) 6
corticotroph adenomas (6) 6
cushings-disease (6) 6
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Clinical Epidemiology, ISSN 1179-1349, 01/2015, Volume 7, pp. 281 - 293
textabstractCushing’s syndrome is a rare disorder resulting from prolonged exposure to excess glucocorticoids. Early diagnosis and treatment of Cushing’s... 
Cushing’s syndrome | Treatment | Epidemiology | Hypercortisolemia
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2008, Volume 26, Issue 13, pp. 2124 - 2130
Purpose Despite the fact that most gastroenteropancreatic neuroendocrine tumors (GEPNETs) are slow-growing, median overall survival ( OS) in patients with... 
LIVER METASTASES | STREPTOZOCIN | CHEMOEMBOLIZATION | SOUTHWEST-ONCOLOGY-GROUP | ONCOLOGY | CARCINOID-TUMORS | RADIONUCLIDE THERAPY | ENDOCRINE TUMORS | PHASE-II | METASTATIC NEUROENDOCRINE TUMORS | EPIDEMIOLOGY | Gastrointestinal Neoplasms - mortality | Humans | Middle Aged | Male | Gastrointestinal Neoplasms - pathology | Time Factors | Myelodysplastic Syndromes - chemically induced | Neuroendocrine Tumors - diagnostic imaging | Aged, 80 and over | Organometallic Compounds - therapeutic use | Adult | Female | Pancreatic Neoplasms - mortality | Neuroendocrine Tumors - pathology | Severity of Illness Index | Hematologic Diseases - chemically induced | Octreotide - analogs & derivatives | Risk Assessment | Organometallic Compounds - adverse effects | Pancreatic Neoplasms - pathology | Proportional Hazards Models | Carcinoid Tumor - diagnostic imaging | Octreotide - adverse effects | Logistic Models | Treatment Outcome | Octreotide - therapeutic use | Carcinoid Tumor - pathology | Disease-Free Survival | Gastrointestinal Neoplasms - diagnostic imaging | Neuroendocrine Tumors - mortality | Radionuclide Imaging | Aged | Chemical and Drug Induced Liver Injury | Radiopharmaceuticals - adverse effects | Carcinoid Tumor - mortality | Pancreatic Neoplasms - diagnostic imaging | Radiopharmaceuticals - therapeutic use | Index Medicus
Journal Article
Neuroendocrinology: international journal for basic and clinical studies on neuroendocrine relationships, ISSN 0028-3835, 09/2010, Volume 92, Issue SUPPL. 1, pp. 111 - 115
Conference Proceeding
Journal Article
Clinical Cancer Research, ISSN 1078-0432, 08/2017, Volume 23, Issue 16, pp. 4617 - 4624
Purpose: Bronchial and gastroenteropancreatic neuroendocrine tumors (NET) are slow-growing tumors, which frequently express somatostatin receptors on their... 
RADIOLABELED SOMATOSTATIN ANALOG | Y-90-DOTATOC | GRADING SYSTEM | PRRT | LU-177-OCTREOTATE | PROGNOSTIC-FACTORS | ONCOLOGY | GUIDELINES | RECEPTOR RADIONUCLIDE THERAPY | CHEMOTHERAPY | LANREOTIDE | Outcome Assessment (Health Care) - methods | Humans | Middle Aged | Male | Intestinal Neoplasms - radiotherapy | Leukemia - etiology | Time Factors | Aged, 80 and over | Organometallic Compounds - therapeutic use | Adult | Female | Stomach Neoplasms - radiotherapy | Acute Disease | Octreotide - analogs & derivatives | Organometallic Compounds - adverse effects | Kaplan-Meier Estimate | Octreotide - adverse effects | Pancreatic Neoplasms - radiotherapy | Treatment Outcome | Octreotide - therapeutic use | Myelodysplastic Syndromes - etiology | Neuroendocrine Tumors - radiotherapy | Bronchial Neoplasms - radiotherapy | Outcome Assessment (Health Care) - statistics & numerical data | Aged | Radiopharmaceuticals - adverse effects | Radiopharmaceuticals - therapeutic use | Therapy | Membranes | Toxicity | Leukemia | Liver | Radioisotopes | Myelodysplastic syndrome | Metastases | Confidence intervals | Receptors | Safety engineering | Somatostatin | Safety | Effectiveness | Kidneys | Cell membranes | Survival | Patients | Lutetium | Experimental design | Renal failure | Somatostatin receptors | Tumors | Cancer | Neuroendocrine tumors
Journal Article
Journal Article
The Journal of Clinical Endocrinology & Metabolism, ISSN 0021-972X, 12/2005, Volume 90, Issue 12, pp. 6403 - 6409
Journal Article